
Zacks has highlighted three buy-ranked value stocks for October 6th: Elanco Animal Health (ELAN), HF Sinclair (DINO), and Embecta Corp. (EMBC), each holding a Zacks Rank #1 and experiencing significant upward revisions in current year earnings estimates, notably HF Sinclair's at 24.8% over 60 days. Concurrently, Zacks' Research Chief identified an unnamed satellite-based communications firm as a "Stock Most Likely to Double," citing its potential within the trillion-dollar space industry and a projected major revenue breakout by 2025.
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time. You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. If you wish to go to ZacksTrade, click OK. If you do not, click Cancel. Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 6th: Elanco Animal Health Incorporated (ELAN - Free Report) : This animal health company carries a Zacks Rank 1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days. Elanco Animal Health Incorporated Price and Consensus HF Sinclair Corporation (DINO - Free Report) : This independent energy company carries a Zacks Rank 1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 24.8% over the last 60 days. Embecta Corp. (EMBC - Free Report) : This medical device company carries a Zacks Rank 1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.3% over the last 60 days. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Image: Bigstock Best Value Stocks to Buy for October 6th Here are three stocks with buy rank and strong value characteristics for investors to consider today, October 6th: Elanco Animal Health Incorporated (ELAN - Free Report) : This animal health company carries a Zacks Rank 1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days. Elanco Animal Health Incorporated Price and Consensus Elanco Animal Health Incorporated price-consensus-chart | Elanco Animal Health Incorporated Quote Elanco Animal Health Incorporated PE Ratio (TTM) Elanco Animal Health Incorporated pe-ratio-ttm | Elanco Animal Health Incorporated Quote HF Sinclair Corporation Price and Consensus HF Sinclair Corporation price-consensus-chart | HF Sinclair Corporation Quote HF Sinclair Corporation PE Ratio (TTM) HF Sinclair Corporation pe-ratio-ttm | HF Sinclair Corporation Quote Embecta Corp. Price and Consensus Embecta Corp. price-consensus-chart | Embecta Corp. Quote Embecta Corp. PE Ratio (TTM) Embecta Corp. pe-ratio-ttm | Embecta Corp. Quote See the full list of top ranked stocks here. Learn more about the Value score and how it is calculated here. Zacks' Research Chief Names "Stock Most Likely to Double" Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest. This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%. Free: See Our Top Stock And 4 Runners Up Zacks Investment Research has identified three stocks across disparate sectors—Elanco Animal Health (ELAN), HF Sinclair (DINO), and Embecta Corp. (EMBC)—as possessing strong value characteristics and a top-tier Zacks Rank 1. The positive sentiment is underpinned by significant upward revisions to their current-year consensus earnings estimates over the past 60 days. Notably, independent energy company HF Sinclair has seen its earnings estimate surge by 24.8%, suggesting a powerful near-term catalyst or a sharp improvement in analyst outlook. Elanco, an animal health firm, and Embecta, a medical device company, also saw material positive revisions of 4.8% and 4.3%, respectively. This combination of a 1 Rank and rising estimates indicates that recent fundamental improvements may not yet be fully reflected in their stock prices, presenting a potential value opportunity. The article also highlights a separate, unnamed satellite communications firm as a high-growth prospect, forecasting a major revenue breakout in 2025, which is presented as a more speculative, high-reward play.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment